Norway - Lipid Modifying Medicine Use

Since 2014, Norway Lipid Modifying Medicine Use was up 3.3% year on year. At 145.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 4 comparing other countries in Lipid Modifying Medicine Use. Norway is overtaken by Belgium, which was ranked number 3 with 145.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Slovenia at 140.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.5% versus 2018. Lithuania recorded the best 5 years average growth at +15% per year, while Slovakia was the worst growing country at -7% per year.

Loading...

Date Units (Defined Daily Dosage) Per Thousand Persons Per Day
2019 145.40
2018 142.20
2017 135.60
2016 131.80
2015 128.60
Download all data from 1999 to 2019

How does Norway rank in Lipid Modifying Medicine Use?

# 28 Countries Units (Defined Daily Dosage) Per Thousand Persons Per Day Last YoY 5‑years CAGR
1 #1
Denmark
160 2019 +3.5 % +3.8 % View data
2 #2
United Kingdom
153 2019 +1.7 % +2.3 % View data
3 #3
Belgium
146 2019 +2.5 % +2.2 % View data
4 #4
Norway
145 2019 +2.3 % +3.3 % View data
5 #5
Slovenia
141 2019 +3.4 % +4.6 % View data
Compare all 28 countries

Go Top